TY - JOUR T1 - Dynamics of Transmission and Control of COVID-19: A Real-time Estimation Using the Kalman Filter JF - medRxiv DO - 10.1101/2020.04.19.20071886 SP - 2020.04.19.20071886 AU - Francisco Arroyo Marioli AU - Francisco Bullano AU - Carlos Rondón-Moreno Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/22/2020.04.19.20071886.abstract N2 - The COVID-19 pandemic has become the center of attention for both researchers and authorities. In this paper, we propose and test a methodology to estimate the daily effective reproduction number (ℛt) through the lens of the Kalman Filter and Bayesian estimation. Moreover, we apply our method to data from the current COVID-19 pandemic in China, Italy, Japan, and South Korea. We correlate our findings with the implementation of control measures in each of these countries. Our results show that China, Italy, and South Korea have been able to reduce ℛt over time. We find significant heterogeneity in the way ℛt decreases across countries. For instance, China reduced ℛt from its peak to below one in 19 days, while South Korea achieved the same reduction in 12 days. In contrast, it has taken Italy almost a month to reach similar levels. We hypothesize this is related to how strict, enforceable, and comprehensive are the implemented policies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received for the purposes of writing this paperAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used for the paper is available in our website. https://sites.google.com/g.ucla.edu/trackingrt ER -